Stock Analiz

Bio-rad Laboratories, Inc. (BIO) stock forecast and price target

Price $366.36 · data as of November 13, 2026

12-month price target

Average target$356.67
Upside / downside−2.6%
Analysts3
ConsensusHold
Low $280.00Average $356.67High $440.00

Gold marker: average target · white marker: today’s price ($366.36)

Analyst ratings

Strong buy 1Buy 0Hold 1Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$9.61−3.2%$2.6B
Next fiscal year
ends December 31, 2027
$9.91+3.1%$2.6B
Next quarter
ends December 31, 2026
$2.83+12.8%$689M
Quarter after
ends March 31, 2027
$2.83+49.7%$611M

Consensus of the analysts covering Bio-rad Laboratories, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 2.6% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Bio-rad Laboratories’s intrinsic value about 62% below today’s market value, and it scores 2.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Bio-rad Laboratories stock price target?

The average 12-month target from 3 analysts is $356.67, 2.6% below the current price of $366.36 Targets range from $280.00 to $440.00.

Is Bio-rad Laboratories a buy according to analysts?

The consensus rating is “Hold” (1 strong buy, 1 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Bio-rad Laboratories expected to earn?

Analysts expect EPS of $9.61 for the fiscal year ending December 31, 2026 and $9.91 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.